SU‐E‐T‐539: Dosimetric Evaluation of PTV Margins and Intrafraction Motion for Prostate SBRT

L. Jiang, H. li, J. Heinzerling, T. Boike, T. Solberg, R. Foster

Research output: Contribution to journalArticle

Abstract

Purpose: We have initiated a phase I/II prostate SBRT trial using doses up to 50 Gy delivered in 5 fractions. With the small requisite margins, intrafraction prostate motion may compromise target coverage and/or dose to organs at risk. The purpose of this study is to investigate CTV coverage and dose to normal tissues, in the presence of intrafraction prostate motion, when different PTV margins and rectal immobilization strategies are employed. Methods: Nine prostate cancer patients treated with a rectal balloon and stereotactic body frame were selected for this study. Patients received 50 Gy in five fractions delivered with 13 coplanar 10 MV photon beams. The SBRT plans used 0, 1,2, and 3mm PTV margins. The tracking data from the Calypso Localization System were used to calculate motion probability density functions (PDFs). Calypso tracking data from conventionally fractionated prostate patients, treated without rectal balloons, were used to generate another set of PDFs. The planned static dose distributions were convolved with the PDFs to generate the delivered dose distributions. The planned and delivered doses were evaluated. Results: The mean planned dose to the CTV, PTV and bladder was slightly higher than the delivered dose. The CTV volume covered by the prescription dose decreased when intrafraction motion is accounted for, but remains 100% with 3mm margins and greater than 97% for no PTV margin. The mean planned dose to anterior rectal wall was less than the delivered dose and the conventionally fractionated group was higher than the SBRT group. Conclusions: This study demonstrates that the dosimetric impact of intrafraction motion during prostate SBRT delivery with 3mm margins is not clinically significant with or without a rectal balloon. Use of a rectal balloon can reduce the delivered dose to the rectum and the severity of early bowel toxicity.

Original languageEnglish (US)
Pages (from-to)3613
Number of pages1
JournalMedical Physics
Volume38
Issue number6
DOIs
StatePublished - 2011

Fingerprint

Prostate
Organs at Risk
Photons
Rectum
Immobilization
Prescriptions
Prostatic Neoplasms
Urinary Bladder
thiacloprid

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

Jiang, L., li, H., Heinzerling, J., Boike, T., Solberg, T., & Foster, R. (2011). SU‐E‐T‐539: Dosimetric Evaluation of PTV Margins and Intrafraction Motion for Prostate SBRT. Medical Physics, 38(6), 3613. https://doi.org/10.1118/1.3612501

SU‐E‐T‐539 : Dosimetric Evaluation of PTV Margins and Intrafraction Motion for Prostate SBRT. / Jiang, L.; li, H.; Heinzerling, J.; Boike, T.; Solberg, T.; Foster, R.

In: Medical Physics, Vol. 38, No. 6, 2011, p. 3613.

Research output: Contribution to journalArticle

Jiang, L, li, H, Heinzerling, J, Boike, T, Solberg, T & Foster, R 2011, 'SU‐E‐T‐539: Dosimetric Evaluation of PTV Margins and Intrafraction Motion for Prostate SBRT', Medical Physics, vol. 38, no. 6, pp. 3613. https://doi.org/10.1118/1.3612501
Jiang, L. ; li, H. ; Heinzerling, J. ; Boike, T. ; Solberg, T. ; Foster, R. / SU‐E‐T‐539 : Dosimetric Evaluation of PTV Margins and Intrafraction Motion for Prostate SBRT. In: Medical Physics. 2011 ; Vol. 38, No. 6. pp. 3613.
@article{650a16f177104b8d996ab412fbd1134e,
title = "SU‐E‐T‐539: Dosimetric Evaluation of PTV Margins and Intrafraction Motion for Prostate SBRT",
abstract = "Purpose: We have initiated a phase I/II prostate SBRT trial using doses up to 50 Gy delivered in 5 fractions. With the small requisite margins, intrafraction prostate motion may compromise target coverage and/or dose to organs at risk. The purpose of this study is to investigate CTV coverage and dose to normal tissues, in the presence of intrafraction prostate motion, when different PTV margins and rectal immobilization strategies are employed. Methods: Nine prostate cancer patients treated with a rectal balloon and stereotactic body frame were selected for this study. Patients received 50 Gy in five fractions delivered with 13 coplanar 10 MV photon beams. The SBRT plans used 0, 1,2, and 3mm PTV margins. The tracking data from the Calypso Localization System were used to calculate motion probability density functions (PDFs). Calypso tracking data from conventionally fractionated prostate patients, treated without rectal balloons, were used to generate another set of PDFs. The planned static dose distributions were convolved with the PDFs to generate the delivered dose distributions. The planned and delivered doses were evaluated. Results: The mean planned dose to the CTV, PTV and bladder was slightly higher than the delivered dose. The CTV volume covered by the prescription dose decreased when intrafraction motion is accounted for, but remains 100{\%} with 3mm margins and greater than 97{\%} for no PTV margin. The mean planned dose to anterior rectal wall was less than the delivered dose and the conventionally fractionated group was higher than the SBRT group. Conclusions: This study demonstrates that the dosimetric impact of intrafraction motion during prostate SBRT delivery with 3mm margins is not clinically significant with or without a rectal balloon. Use of a rectal balloon can reduce the delivered dose to the rectum and the severity of early bowel toxicity.",
author = "L. Jiang and H. li and J. Heinzerling and T. Boike and T. Solberg and R. Foster",
year = "2011",
doi = "10.1118/1.3612501",
language = "English (US)",
volume = "38",
pages = "3613",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐E‐T‐539

T2 - Dosimetric Evaluation of PTV Margins and Intrafraction Motion for Prostate SBRT

AU - Jiang, L.

AU - li, H.

AU - Heinzerling, J.

AU - Boike, T.

AU - Solberg, T.

AU - Foster, R.

PY - 2011

Y1 - 2011

N2 - Purpose: We have initiated a phase I/II prostate SBRT trial using doses up to 50 Gy delivered in 5 fractions. With the small requisite margins, intrafraction prostate motion may compromise target coverage and/or dose to organs at risk. The purpose of this study is to investigate CTV coverage and dose to normal tissues, in the presence of intrafraction prostate motion, when different PTV margins and rectal immobilization strategies are employed. Methods: Nine prostate cancer patients treated with a rectal balloon and stereotactic body frame were selected for this study. Patients received 50 Gy in five fractions delivered with 13 coplanar 10 MV photon beams. The SBRT plans used 0, 1,2, and 3mm PTV margins. The tracking data from the Calypso Localization System were used to calculate motion probability density functions (PDFs). Calypso tracking data from conventionally fractionated prostate patients, treated without rectal balloons, were used to generate another set of PDFs. The planned static dose distributions were convolved with the PDFs to generate the delivered dose distributions. The planned and delivered doses were evaluated. Results: The mean planned dose to the CTV, PTV and bladder was slightly higher than the delivered dose. The CTV volume covered by the prescription dose decreased when intrafraction motion is accounted for, but remains 100% with 3mm margins and greater than 97% for no PTV margin. The mean planned dose to anterior rectal wall was less than the delivered dose and the conventionally fractionated group was higher than the SBRT group. Conclusions: This study demonstrates that the dosimetric impact of intrafraction motion during prostate SBRT delivery with 3mm margins is not clinically significant with or without a rectal balloon. Use of a rectal balloon can reduce the delivered dose to the rectum and the severity of early bowel toxicity.

AB - Purpose: We have initiated a phase I/II prostate SBRT trial using doses up to 50 Gy delivered in 5 fractions. With the small requisite margins, intrafraction prostate motion may compromise target coverage and/or dose to organs at risk. The purpose of this study is to investigate CTV coverage and dose to normal tissues, in the presence of intrafraction prostate motion, when different PTV margins and rectal immobilization strategies are employed. Methods: Nine prostate cancer patients treated with a rectal balloon and stereotactic body frame were selected for this study. Patients received 50 Gy in five fractions delivered with 13 coplanar 10 MV photon beams. The SBRT plans used 0, 1,2, and 3mm PTV margins. The tracking data from the Calypso Localization System were used to calculate motion probability density functions (PDFs). Calypso tracking data from conventionally fractionated prostate patients, treated without rectal balloons, were used to generate another set of PDFs. The planned static dose distributions were convolved with the PDFs to generate the delivered dose distributions. The planned and delivered doses were evaluated. Results: The mean planned dose to the CTV, PTV and bladder was slightly higher than the delivered dose. The CTV volume covered by the prescription dose decreased when intrafraction motion is accounted for, but remains 100% with 3mm margins and greater than 97% for no PTV margin. The mean planned dose to anterior rectal wall was less than the delivered dose and the conventionally fractionated group was higher than the SBRT group. Conclusions: This study demonstrates that the dosimetric impact of intrafraction motion during prostate SBRT delivery with 3mm margins is not clinically significant with or without a rectal balloon. Use of a rectal balloon can reduce the delivered dose to the rectum and the severity of early bowel toxicity.

UR - http://www.scopus.com/inward/record.url?scp=85024814001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024814001&partnerID=8YFLogxK

U2 - 10.1118/1.3612501

DO - 10.1118/1.3612501

M3 - Article

AN - SCOPUS:85024814001

VL - 38

SP - 3613

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -